cyclopropanecarboxamide has been researched along with alpha-aminopyridine in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Beuckmann, CT; Doko, T; Naoe, Y; Ozaki, F; Ozaki, S; Sorimachi, K; Suzuki, M; Takemura, A; Tanaka, T; Terauchi, T; Ueno, T; Yonaga, M; Yoshida, Y | 1 |
1 other study(ies) available for cyclopropanecarboxamide and alpha-aminopyridine
Article | Year |
---|---|
Discovery of (1R,2S)-2-{[(2,4-Dimethylpyrimidin-5-yl)oxy]methyl}-2-(3-fluorophenyl)-N-(5-fluoropyridin-2-yl)cyclopropanecarboxamide (E2006): A Potent and Efficacious Oral Orexin Receptor Antagonist.
Topics: Administration, Oral; Amides; Aminopyridines; Animals; Calcium; Cells, Cultured; Cyclopropanes; Drug Design; Drug Discovery; Humans; Male; Mice; Mice, Inbred C57BL; Microsomes, Liver; Models, Molecular; Molecular Structure; Orexin Receptor Antagonists; Orexin Receptors; Pyrimidines; Structure-Activity Relationship | 2015 |